New alarm over China controlling drug supply chains
Axios reports that the National Security Commission on Emerging Biotechnology warns, in a new analysis released Thursday, that China is intensifying efforts to control the entire drug supply chain, which it says puts the U.S. at risk of being cut off from future lifesaving treatments. According to Axios, Western drug companies have invested heavily in Chinese biotechs to strengthen their product pipelines, but sharing capital and expertise could give Beijing more control over critical pharmaceutical technologies.
Based on Axios's report - only one outlet has covered this so far. Read the original.Coverage 1 source · 1 report
Chronological.
-
New alarm over China controlling drug supply chains
China is intensifying efforts to control the entire drug supply chain, putting the U.S. at risk of being cut off from future lifesaving treatments, the National Security Commission on Emerging Biotechnology warns in a new analysis out Thursday. Why it matters: Western drug giants have invested huge sums in Chinese biotechs to boost their product pipelines. But sharing capital and expertise could give Beijing more control over critical pharmaceutical technologies. Concerns about the U.S. getting
Discussion 0 comments